Literature DB >> 35429247

Menstrual Cycle Related Fluctuations in Circulating Markers of Bone Metabolism at Rest and in Response to Running in Eumenorrheic Females.

Anne Guzman1, Nigel Kurgan1, Sara C Moniz2, Seth F McCarthy2, Craig Sale3, Heather Logan-Sprenger4, Kirsty J Elliott-Sale3, Tom J Hazell2, Panagiota Klentrou5.   

Abstract

This study examined potential fluctuations in bone metabolic markers across the menstrual cycle both at rest and after a 30-min bout of continuous running at 80% of V̇O2max. Resting and post-exercise (0, 30, 90 min) sclerostin, parathyroid hormone (PTH), carboxy-terminal cross-linking telopeptide of type I collagen (β-CTXI), and procollagen type 1 N propeptide (PINP) were assessed in 10 eumenorrheic women (age: 21 ± 3 y, BMI: 23.2 ± 3.0 kg.m2) during the mid- to late-follicular (FP: day 8.0 ± 1.4) and mid-luteal (LP: day 22.0 ± 2.5) phases of the menstrual cycle. Ovulation was determined using ovulation kits and daily measurement of oral body temperature upon awakening. Menstrual cycle phase was subsequently confirmed by measurement of plasma estradiol and progesterone. On average, resting estradiol concentrations increased from 46.3 ± 8.9 pg·mL-1 in the FP to 67.3 ± 23.4 pg·mL-1 in the LP (p = 0.015), and resting progesterone increased from 4.12 ± 2.36 ng·mL-1 in the FP to 11.86 ± 4.49 ng·mL-1 in the LP (p < 0.001). At rest, there were no differences between menstrual cycle phases in sclerostin (FP: 260.1 ± 135.0 pg·mL-1; LP: 303.5 ± 99.9 pg·mL-1; p = 0.765), PTH (FP: 0.96 ± 0.64 pmol·L-1; LP: 0.79 ± 0.44 pmol·L-1; p = 0.568), β-CTXI (FP: 243.1 ± 158.0 ng·L-1; LP: 202.4 ± 92.3 ng·L-1; p = 0.198), and PINP (FP: 53.6 ± 8.9 μg·L-1; LP: 66.2 ± 20.2 μg·L-1; p = 0.093). Main effects for time (p < 0.05) were shown in sclerostin, PTH, β-CTXI and PINP, without phase or interaction effects. Sclerostin increased from pre- to immediately post-exercise (45%; p = 0.007), and so did PTH (43%; p = 0.011), both returning to resting concentrations 30 min post-exercise. β-CTXI decreased from pre- to post-exercise (20%; p = 0.027) and was still below its pre-exercise concentrations at 90 min post-exercise (17%; p = 0.013). PINP increased immediately post-exercise (29%; p < 0.001), returning to resting concentrations at 30 min post-exercise. These results demonstrate no effect of menstrual cycle phase on resting bone marker concentrations or on the bone metabolic marker response to intense exercise.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Menstrual phases; P1NP; PTH; Running; Sclerostin; β-CTXI

Mesh:

Substances:

Year:  2022        PMID: 35429247     DOI: 10.1007/s00223-022-00970-4

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.000


  52 in total

Review 1.  Estrogen and the skeleton.

Authors:  Sundeep Khosla; Merry Jo Oursler; David G Monroe
Journal:  Trends Endocrinol Metab       Date:  2012-05-16       Impact factor: 12.015

2.  Estrogen regulation of human osteoblastic cell proliferation and differentiation.

Authors:  J A Robinson; S A Harris; B L Riggs; T C Spelsberg
Journal:  Endocrinology       Date:  1997-07       Impact factor: 4.736

Review 3.  Bone remodeling: A review of the bone microenvironment perspective for fragility fracture (osteoporosis) of the hip.

Authors:  Nicola L Fazzalari
Journal:  Semin Cell Dev Biol       Date:  2008-08-14       Impact factor: 7.727

Review 4.  Direct and indirect estrogen actions on osteoblasts and osteoclasts.

Authors:  Alberta Zallone
Journal:  Ann N Y Acad Sci       Date:  2006-04       Impact factor: 5.691

Review 5.  The normal menstrual cycle in women.

Authors:  M Mihm; S Gangooly; S Muttukrishna
Journal:  Anim Reprod Sci       Date:  2010-09-03       Impact factor: 2.145

Review 6.  Estrogen and bone health in men and women.

Authors:  Jane A Cauley
Journal:  Steroids       Date:  2014-12-30       Impact factor: 2.668

7.  Unique effects of energy versus estrogen deficiency on multiple components of bone strength in exercising women.

Authors:  E A Southmayd; R J Mallinson; N I Williams; D J Mallinson; M J De Souza
Journal:  Osteoporos Int       Date:  2016-12-28       Impact factor: 4.507

Review 8.  Estrogen deficiency and bone loss: an inflammatory tale.

Authors:  M Neale Weitzmann; Roberto Pacifici
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

Review 9.  Hormone treatment of endometriosis: the estrogen threshold hypothesis.

Authors:  R L Barbieri
Journal:  Am J Obstet Gynecol       Date:  1992-02       Impact factor: 8.661

10.  Fasted plasma asprosin concentrations are associated with menstrual cycle phase, oral contraceptive use and training status in healthy women.

Authors:  A N Leonard; A L Shill; A E Thackray; D J Stensel; Nicolette C Bishop
Journal:  Eur J Appl Physiol       Date:  2020-12-08       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.